GDF-8

GDF-8

GDF-8 Overview

Molecule Name
Growth/differentiation factor 8
Synonyms
GDF-8, Myostatin, GDF8, MSTN, Growth,differentiation factor 8
Drug Development Progress
Drugs in Clinical Trials8
Approved Drugs0
Highest Development StageNDA/BLA
Target Synonym
MSTN,GDF-8,GDF8,Growth Differentiation Factor 8,MSLHP,Myostatin,Growth/Differentiation Factor 8
Background
Growth differentiation factor 8 (GDF8), also known as myostatin, is a unique member of the transforming growth factor-β superfamily that is expressed in human granulosa cells and has important roles in regulating a variety of ovarian functions. GDF8 acts as a negative regulator of skeletal muscle growth and differentiation. In addition to the expression in the musculoskeletal system, GDF8 is also expressed in various tissues, including the reproductive system.

GDF-8 Product List

Species
  • Human(5)
  • Cynomolgus(2)
  • Mouse(2)
  • Human / Cynomolgus / Mouse / Rat(1)
Tag
  • His Tag(5)
  • His Tag & Avi Tag(3)
  • Avi Tag(1)
  • Tag Free(1)
Host
  • HEK293(7)
  • CHO(3)
Conjugate
  • Biotin-labeled(5)
  • Unconjugated(5)
Grade
  • RUO(10)
Low Endotoxin
  • Yes(5)
  • No(5)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
GDF-8
Human latent GDF-8 Protein, His Tag, low endotoxin (pro & latent) (Mass Spec & MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPR

$415.00

50ug
GDF-8
Human / Cynomolgus / Mouse / Rat GDF-8 Protein, Tag Free, low endotoxin
Human / Cynomolgus / Mouse / Rat
CHO
SDS-PAGE
ELISA

$370.00

50ug
GDF-8
Human latent GDF-8 Protein, His Tag, low endotoxin (MALS verified)
Human
CHO
MALSSDS-PAGE
ELISA

$360.00

50ug
GDF-8
Cynomolgus Latent GDF-8 Protein, His Tag, low endotoxin (pro & latent)
Cynomolgus
HEK293
SDS-PAGE
ELISASPR

$368.00

50ug
GDF-8
Biotinylated Cynomolgus latent GDF-8 Protein, Avitag™,His Tag
Cynomolgus
HEK293
SDS-PAGE
ELISASPR

$360.00

25ug
GDF-8
Biotinylated Human latent GDF-8 Protein, His Tag, ultra sensitivity (primary amine labeling) (pro & latent) (MALS verified)
Human
HEK293
MALSSDS-PAGE
SPR

$300.00

25ug
GDF-8
Biotinylated Human latent GDF-8 Protein, His,Avitag™ (pro & latent)
Human
HEK293
SDS-PAGE
ELISASPR

$415.00

25ug
GDF-8
Biotinylated Human GDF-8 Protein, Avitag™
Human
CHO
SDS-PAGE
ELISASPR

$365.00

25ug
GDF-8
Mouse latent GDF-8 Protein, His Tag, low endotoxin (pro & latent)
Mouse
HEK293
SDS-PAGE
ELISASPR

$360.00

50ug
GDF-8
Biotinylated Mouse latent GDF-8 Protein, Avitag™,His Tag (pro & latent) 
Mouse
HEK293
SDS-PAGE
ELISASPR

$360.00

25ug
You Have Viewed 1-10 Of 10 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Talditercept alfaRO-7239361; BMS-986089; RG-6206; BHV-2000Phase 3 ClinicalBristol-Myers Squibb Company
Muscular Atrophy, Spinal; Muscular Dystrophy, Duchenne; Neuromuscular Diseases; Obesity; Overweight
Details
EmugrobartGYM-329; RG-6237; RG-70240; RO-7204239Phase 3 ClinicalChugai Pharmaceutical Co Ltd
Diabetes Mellitus, Type 2; Muscular Atrophy, Spinal; Muscular Dystrophy, Facioscapulohumeral; Obesity; Overweight
Details
TrevogrumabREGN-1033; REGN1033; SAR-391786; GDF8Phase 2 ClinicalRegeneron Pharmaceuticals Inc
Myositis, Inclusion Body; Obesity; Sarcopenia
Details
AAV1-FS344AAV1-Follistatin; AAV1-FS344Phase 2 ClinicalNationwide Children'S Hospital
Becker muscular dystrophy; Muscular Dystrophy, Duchenne; Myositis, Inclusion Body
Details
EL-22EL-22Phase 1 Clinical
Obesity
Details
IBIO-600IBIO-600Phase 1 ClinicalAstralBio Inc
Obesity; Overweight
Details
RinvaterceptRKER-065; KER-065Phase 1 ClinicalKeros Therapeutics Inc
Neuromuscular Diseases; Obesity
Details
SRK-439SRK-439Phase 1 ClinicalScholar Rock Inc
Heart Diseases; Obesity
Details
Customer Reviews